Overview
The purpose of this study is to use a survey to measure reflux symptoms in patients with Cystic Fibrosis who are on reflux treatment, and to monitor their symptoms after stopping the reflux treatment.
Eligibility
Inclusion Criteria:
- Children 6-17 years of age with a confirmed CF diagnosis by either a positive sweat test or 2 disease causing CFTR mutations.
- GERD medications documented at visit 1
- Stable GERD medication dose for 3 months
- Pediatric GERD Symptom Assessment Score <80
- Signed consent
Exclusion Criteria:
- Declining to participate in the study or sign consent
- Unwillingness to stop GERD therapy
- History of severe GERD per gastroenterology diagnosis and documentation
- GSAS score >80